U.S. National Library Medicine

[kc_row use_container=”yes” force=”no” column_align=”middle” video_mute=”no” _id=”273467″][kc_column width=”12/12″ video_mute=”no” _id=”106671″][kc_column_text _id=”866636″]

[/kc_column_text][/kc_column][/kc_row][kc_row _id=”159838″][kc_column width=”12/12″ video_mute=”no” _id=”60618″][kc_column_text _id=”39734″]

A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Diseas (COVID-19) 32247318.pdf

Clinicaltrials.gov COVID19.xlsx

Clinicaltrias_gov 30marzo2020 230 resultados.ris

EU_clinicaltrial_30_03_2020.txt

Hydroxychloroquine and azithromycin as a treatment of COVID-19_32205204.pdf

ICTRP covid-19-trials.xlsx

Prospective registration and reporting of trial number in randomised clinical trials_global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations-32291261.pdf

SARS-CoV-2 Seroconversion in Humans- A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup_32302069.pdf

The FDA-approved Drug Ivermectin inhibits the replication of SARS-1 CoV-2 in vitro..pdf

[/kc_column_text][/kc_column][/kc_row]